博雅生物:公司2025年年度非经营性资金占用及其他关联资金往来情况汇总表

                                                                                                                  金额单位：万元

非经营性资金占用 资金占用  占用方与上市  上市公司核算  2025年期初占 2025年度占用 2025年度占  2025年度偿  2025年期  占用形成  占用性质

                方名称    公司的关联关  的会计科目    用资金余额  累计发生金额 用资金的利  还累计发生  末占用资  原因

                          系                                        (不含利息)    息(如有)    金额        金余额

控股股东、实际控        无        不适用        不适用            -            -          -          -        -    不适用          不适用
制人及其附属企业

小计                                                                -            -          -          -        -

前控股股东、实际

控制人及其附属企        无        不适用        不适用            -            -          -          -        -    不适用          不适用
业

小计                                                                -            -          -          -        -

其他关联方及其附        无        不适用        不适用            -            -          -          -        -    不适用          不适用
属企业

小计                                                                -            -          -          -        -

总计                                                                -            -          -          -        -


                              2025年度非经营性资金占用及其他关联资金往来情况汇总表(续)

                                                                                                                    金额单位：万元
                                                                  2025年度往                        2025

其他关联                往来方与上市公 上市公司核算  2025年期  来累计发生  2025年度  2025年度  年因处  2025年期  往来形成原 往来性质（经
资金往来 资金往来方名称  司的关联关系  的会计科目  初往来资金 金额(不含利 往来资金的 偿还累计发 置子公 末往来资金    因    营性往来、非
                                                          余额        息)      利息(如有)  生金额  司而减    余额                经营性往来）
                                                                                                        少

        河南德信行大药 受同一母公司控 应收账款 / 应      30.83        3.66          -      34.49      -          - 药品销售  经营性往来

        房有限公司    制            收款项融资

        华润(南平)医药  受同一母公司控 应收账款 / 应          -      84.79          -      44.90      -      39.89 药品销售  经营性往来

        有限公司      制            收款项融资

        华润安徽医药有 受同一母公司控 应收账款 / 应      137.76      184.03          -    198.85      -    122.94 药品销售  经营性往来

        限公司        制            收款项融资

        华润安阳医药有 受同一母公司控 应收账款 / 应

        限公司新稀特大 制            收款项融资            -      14.10          -          -      -      14.10 药品销售  经营性往来

        药房

        华润昂德生物药 受同一母公司控 应收账款 / 应      43.80      42.00          -      85.80      -          - 药品销售  经营性往来

        业有限公司    制            收款项融资

        华润亳州中药有 受同一母公司控 应收账款 / 应          -      62.27          -      49.39      -      12.88 药品销售  经营性往来

        限公司        制            收款项融资

        华润东大(福建)  受同一母公司控 应收账款 / 应      355.14    1,038.01          -    882.49      -    510.66 药品销售  经营性往来

        医药有限公司  制            收款项融资

        华润恩施医药有 受同一母公司控 应收账款 / 应      80.54      89.57          -    170.11      -          - 药品销售  经营性往来

        限公司        制            收款项融资

        华润福建医药有 受同一母公司控 应收账款 / 应      520.28      373.40          -    366.74      -    526.94 药品销售  经营性往来

        限公司        制            收款项融资

        华润复大医药  受同一母公司控 应收账款 / 应    1,319.27    4,655.42          -  3,173.91      -  2,800.78 药品销售  经营性往来

        (广东)有限公司  制            收款项融资

        华润广东医药有 受同一母公司控 应收账款 / 应      33.00      333.64          -    207.03      -    159.61 药品销售  经营性往来

        限公司        制            收款项融资

        华润贵州医药有 受同一母公司控 应收账款 / 应          -      112.86          -      2.43      -    110.43 药品销售  经营性往来

        限公司        制            收款项融资

        华润国邦(上海)  受同一母公司控 应收账款 / 应      129.70      188.65          -    250.95      -      67.40 药品销售  经营性往来

        医药有限公司  制            收款项融资

        华润海南裕康医 受同一母公司控 应收账款 / 应      90.01      719.60          -    616.93      -    192.68 药品销售  经营性往来

        药有限公司    制            收款项融资


                              2025年度非经营性资金占用及其他关联资金往来情况汇总表(续)

                                                                                                                    金额单位：万元
                                                                  2025年度往                        2025

其他关联                往来方与上市公 上市公司核算  2025年期  来累计发生  2025年度  2025年度  年因处  2025年期  往来形成原 往来性质（经
资金往来 资金往来方名称  司的关联关系  的会计科目  初往来资金 金额(不含利 往来资金的 偿还累计发 置子公 末往来资金    因    营性往来、非
                                                          余额        息)      利息(如有)  生金额  司而减    余额                经营性往来）
                                                                                                        少

        华润邯郸医药有 受同一母公司控 应收账款 / 应      104.51      83.66          -    182.85      -      5.32 药品销售  经营性往来

        限公司        制            收款项融资

        华润河南医药有 受同一母公司控 应收账款 / 应      214.58    2,520.54          -  1,078.85  1.84  1,654.43 药品销售  经营性往来

        限公司        制            收款项融资

        华润菏泽医药有 受同一母公司控 应收账款 / 应        5.20